Bristol Myers Squibb Co. (BMY)

66.82 -1.27 (-1.87%) USD  |  NYSE  |  Sep 04, 16:00
66.82 0.00 (0.00%) After-Hours: 20:00
More

Bristol Myers Squibb SG&A Expense (TTM) : 7.413B for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for BMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1996. Start Trial.
Date Value
June 30, 2026 7.413B
March 31, 2026 7.30B
December 31, 2025 7.267B
September 30, 2025 7.222B
June 30, 2025 7.416B
March 31, 2025 7.631B
December 31, 2024 8.414B
September 30, 2024 8.351B
June 30, 2024 8.371B
March 31, 2024 8.377B
December 31, 2023 7.772B
September 30, 2023 7.965B
June 30, 2023 7.892B
March 31, 2023 7.745B
December 31, 2022 7.814B
September 30, 2022 7.902B
June 30, 2022 7.76B
March 31, 2022 7.855B
December 31, 2021 7.69B
September 30, 2021 8.057B
June 30, 2021 7.975B
March 31, 2021 7.721B
December 31, 2020 7.661B
September 30, 2020 6.674B
June 30, 2020 6.023B
Date Value
March 31, 2020 5.471B
December 31, 2019 4.871B
September 30, 2019 4.473B
June 30, 2019 4.522B
March 31, 2019 4.577B
December 31, 2018 4.551B
September 30, 2018 4.531B
June 30, 2018 4.574B
March 31, 2018 4.61B
December 31, 2017 4.715B
September 30, 2017 4.86B
June 30, 2017 4.857B
March 31, 2017 4.928B
December 31, 2016 4.911B
September 30, 2016 4.951B
June 30, 2016 4.983B
March 31, 2016 4.88B
December 31, 2015 4.841B
September 30, 2015 4.704B
June 30, 2015 4.728B
March 31, 2015 4.731B
December 31, 2014 4.822B
September 30, 2014 4.78B
June 30, 2014 4.754B
March 31, 2014 4.876B

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Johnson & Johnson 25.14B
Eli Lilly & Co. 12.24B
Merck & Co., Inc. 11.14B
Pfizer Inc. 13.72B
AstraZeneca PLC 585.31M